Nonischemic DCM, LVEF ≤35% and in NYHA II–III (class I) Hypertrophic cardiomyopathy ≥1 major risk factor † (class IIa) Arrhythmogenic right ventricular cardiomyopathy ≥1 risk factor for ...

This cohort had a median age of 74 and was over 60% men. Nearly 55% had a nonischemic cardiomyopathy as opposed to an ...

to evaluate the efficacy and safety of a single dose of AB-1002 administered via antegrade intracoronary artery infusion in patients with nonischemic cardiomyopathy and New York Heart Association ...

and chronic ischemic and nonischemic cardiomyopathy. 1 Stem cell niches are functionally important because they provide a regulatory structure for stem cells, thereby controlling and balancing ...

It appears that the study subjects benefited from EECP to a similar degree, regardless of the ischemic or nonischemic etiology of their heart failure. While a diminution in the ischemic burden in ...